CAS No. |
2069959-72-2 |
|---|---|
英文名称 |
- |
别名 |
Obrindatamab;Research Grade Obrindatamab (DHJ04004);MGD-009;Research Grade Obrindatamab |
用途 |
Obrindatamab can be used in cancer research by mediating redirected cytotoxic T lymphocyte (CTL) activity against B7-H3-expressing cancer cells through its dual binding to B7-H3 and CD3. |
|
|
评论 |
|---|